The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 304,760 | 4,000,000 | SH | OTR | 4,000,000 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 195,467 | 2,175,000 | SH | OTR | 2,175,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 44,350 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 9,475 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 218,498 | 1,123,500 | SH | OTR | 1,123,500 | 0 | 0 | ||
ALLERGAN PLC | SHS | G0177J108 | 1,647,030 | 9,300,000 | SH | OTR | 9,300,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 163,275 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
ALPHABET INC | CAP STK CL C | 02079K107 | 343,230 | 295,173 | SH | OTR | 295,173 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 14,500 | 3,625,000 | SH | OTR | 3,625,000 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 283,800 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 53,580 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 1,924 | 586,497 | SH | OTR | 586,497 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 28,770 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 154,991 | 1,376,349 | SH | OTR | 1,376,349 | 0 | 0 | ||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 12,765 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
AVROBIO INC | COM | 05455M100 | 26,841 | 1,725,000 | SH | OTR | 1,725,000 | 0 | 0 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | 3,063 | 170,164 | SH | OTR | 170,164 | 0 | 0 | ||
BLACKSTONE GROUP INC | COM CL A | 09260D107 | 18,356 | 402,811 | SH | OTR | 402,811 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 133,760 | 35,200,000 | SH | OTR | 35,200,000 | 0 | 0 | ||
BROADMARK RLTY CAP INC | COM | 11135B100 | 53,920 | 7,170,213 | SH | OTR | 7,170,213 | 0 | 0 | ||
BROADMARK RLTY CAP INC | COM | 11135B100 | 17,984 | 2,391,536 | SH | Call | OTR | 2,391,536 | 0 | 0 | |
BROADMARK RLTY CAP INC | *W EXP 11/15/202 | 11135B118 | 1,578 | 7,174,613 | SH | OTR | 7,174,613 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 30,383 | 2,300,000 | SH | OTR | 2,300,000 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 430,723 | 7,250,000 | SH | OTR | 7,250,000 | 0 | 0 | ||
CHARTER COMMUNICATIONS INC N | CL A | 16119P108 | 315,595 | 723,328 | SH | OTR | 723,328 | 0 | 0 | ||
CIGNA CORP NEW | COM | 125523100 | 221,475 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | NOTE 1.250% 5/0 | 189464AC4 | 30,671 | 49,172,000 | PRN | OTR | 49,172,000 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 14,844 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
CTRIP COM INTL LTD | NOTE 1.000% 7/0 | 22943FAF7 | 1,948 | 2,000,000 | PRN | OTR | 2,000,000 | 0 | 0 | ||
CTRIP COM INTL LTD | DBCV 1.990% 7/0 | 22943FAH3 | 1,985 | 2,000,000 | PRN | OTR | 2,000,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 7,369 | 625,000 | SH | OTR | 625,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 41,170 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
DERMTECH INC | COM | 24984K105 | 6,809 | 605,255 | SH | OTR | 605,255 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 341 | 50,113 | SH | OTR | 50,113 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 90,003 | 1,750,000 | SH | OTR | 1,750,000 | 0 | 0 | ||
EQUIFAX INC | COM | 294429105 | 45,185 | 378,275 | SH | OTR | 378,275 | 0 | 0 | ||
EQUINIX INC | COM | 29444U700 | 176,087 | 281,933 | SH | OTR | 281,933 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 172,200 | 10,000,000 | SH | OTR | 10,000,000 | 0 | 0 | ||
FACEBOOK INC | CL A | 30303M102 | 181,399 | 1,087,524 | SH | OTR | 1,087,524 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 66,630 | 3,000,000 | SH | OTR | 3,000,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 55,588 | 1,599,667 | SH | OTR | 1,599,667 | 0 | 0 | ||
FIDELITY NATL INFORMATION SV | COM | 31620M106 | 562,124 | 4,621,208 | SH | OTR | 4,621,208 | 0 | 0 | ||
FORTY SEVEN INC | COM | 34983P104 | 105,439 | 1,105,000 | SH | OTR | 1,105,000 | 0 | 0 | ||
GENERAL DYNAMICS CORP | COM | 369550108 | 275,692 | 2,083,681 | SH | OTR | 2,083,681 | 0 | 0 | ||
GOL LINHAS AEREAS INTLG S A | SPON ADR PFD NEW | 38045R206 | 367 | 85,838 | SH | OTR | 85,838 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 1,015 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 62,700 | 3,113,222 | SH | OTR | 1 | 3,113,222 | 0 | 0 | |
IAC INTERACTIVECORP | COM | 44919P508 | 307,379 | 1,715,000 | SH | OTR | 1,715,000 | 0 | 0 | ||
IHS MARKIT LTD | SHS | G47567105 | 295,532 | 4,925,538 | SH | OTR | 4,925,538 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 45845PAA6 | 1,211 | 1,500,000 | PRN | OTR | 1,500,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | NOTE 2.000% 5/1 | 45845PAB4 | 22,499 | 25,500,000 | PRN | OTR | 25,500,000 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 25,635 | 1,875,300 | SH | OTR | 1,875,300 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 172,126 | 5,750,000 | SH | OTR | 5,750,000 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 403,364 | 3,739,696 | SH | OTR | 3,739,696 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 40,827 | 567,047 | SH | OTR | 567,047 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 25,645 | 1,335,000 | SH | OTR | 1,335,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 49,460 | 35,102,000 | PRN | OTR | 35,102,000 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 10,810 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
MICROSOFT CORP | COM | 594918104 | 287,619 | 1,823,720 | SH | OTR | 1,823,720 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 46,122 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 22,921 | 842,683 | SH | OTR | 842,683 | 0 | 0 | ||
MYOKARDIA INC | COM | 62857M105 | 20,158 | 430,000 | SH | OTR | 430,000 | 0 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 3,504 | 780,484 | SH | OTR | 780,484 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 9,180 | 3,000,000 | SH | OTR | 3,000,000 | 0 | 0 | ||
PALO ALTO NETWORKS INC | COM | 697435105 | 161,783 | 986,721 | SH | OTR | 986,721 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 280 | 84,502 | SH | OTR | 84,502 | 0 | 0 | ||
PLAYA HOTELS & RESORTS NV | SHS | N70544106 | 53,562 | 30,606,930 | SH | OTR | 30,606,930 | 0 | 0 | ||
PRINCIPIA BIOPHARMA INC | COM | 74257L108 | 22,842 | 384,674 | SH | OTR | 384,674 | 0 | 0 | ||
PROGENICS PHARMACEUTICALS IN | COM | 743187106 | 31,350 | 8,250,000 | SH | OTR | 8,250,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 10,590 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | NOTE 3.000% 8/1 | 69366JAB7 | 42,577 | 39,676,000 | PRN | OTR | 39,676,000 | 0 | 0 | ||
QUOTIENT LTD | SHS | G73268107 | 9,875 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 69,134 | 1,440,000 | SH | OTR | 1,440,000 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 26,708 | 2,054,486 | SH | OTR | 2,054,486 | 0 | 0 | ||
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 4,821 | 6,750,000 | PRN | OTR | 6,750,000 | 0 | 0 | ||
READY CAP CORP | COM | 75574U101 | 9,154 | 1,267,896 | SH | OTR | 1,267,896 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 454 | 20,733 | SH | OTR | 20,733 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 19,386 | 675,000 | SH | OTR | 675,000 | 0 | 0 | ||
SALESFORCE COM INC | COM | 79466L302 | 232,454 | 1,614,488 | SH | OTR | 1,614,488 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 34,237 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 10,229 | 4,825,086 | SH | OTR | 4,825,086 | 0 | 0 | ||
SHERWIN WILLIAMS CO | COM | 824348106 | 233,955 | 509,130 | SH | OTR | 509,130 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 721,500 | 2,616,500 | SH | Put | OTR | 2,616,500 | 0 | 0 | |
STEMLINE THERAPEUTICS INC | COM | 85858C107 | 11,374 | 2,350,000 | SH | OTR | 2,350,000 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | NOTE 3.250%11/0 | 88339KAA0 | 15,685 | 16,360,000 | PRN | OTR | 16,360,000 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 352,576 | 1,243,215 | SH | OTR | 1,243,215 | 0 | 0 | ||
TRANSUNION | COM | 89400J107 | 133,941 | 2,023,887 | SH | OTR | 2,023,887 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 22,000 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 11,863 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 34,611 | 365,000 | SH | OTR | 365,000 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 33,426 | 1,375,000 | SH | OTR | 1,375,000 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 9,823 | 3,720,930 | SH | OTR | 3,720,930 | 0 | 0 | ||
VISA INC | COM CL A | 92826C839 | 284,098 | 1,763,268 | SH | OTR | 1,763,268 | 0 | 0 | ||
WABTEC | COM | 929740108 | 304,295 | 6,322,354 | SH | OTR | 6,322,354 | 0 | 0 | ||
XEROX HOLDINGS CORP | COM NEW | 98421M106 | 2,462 | 130,000 | SH | OTR | 130,000 | 0 | 0 | ||
ZEALAND PHARMA A S | SPONSORED ADR | 98920Y304 | 25,875 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 55,643 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 62,073 | 1,750,000 | SH | OTR | 1,750,000 | 0 | 0 |